Patents by Inventor Shivang Doshi

Shivang Doshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for treating solid tumors and other malignancies
    Publication number: 20180207163
    Abstract: A combination of a CDK4/6 inhibitor and an mTOR inhibitor for the treatment of cancer.
    Type: Application
    Filed: March 26, 2018
    Publication date: July 26, 2018
    Inventors: Maria Borland, Christopher Thomas Brain, Shivang Doshi, Sunkyu Kim, Jianguo Ma, Josh Murtie, Hong Zhang
  • Combination therapy comprising a CDK4/6 inhibitor and a PI3K inhibitor for use in the treatment of cancer
    Patent number: 10010552
    Abstract: A combination of a CDK4/6 inhibitor and a P3Kinase inhibitor for the treatment of cancer.
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: July 3, 2018
    Assignee: Novartis AG
    Inventors: Sunkyu Kim, Shivang Doshi, Kristy Haas, Steven Kovats, Alan Xizhong Huang, Yan Chen
  • Pharmaceutical combination comprising binimetinib
    Patent number: 9867825
    Abstract: A combination of a CDK4/6 inhibitor and a MEK inhibitor for the treatment of diseases such as cancer.
    Type: Grant
    Filed: December 16, 2013
    Date of Patent: January 16, 2018
    Assignee: Novartis AG
    Inventors: Giordano Caponigro, Scott Delach, Shivang Doshi, Thomas Horn-Spirohn, Sunkyu Kim
  • Combination therapy
    Patent number: 9408847
    Abstract: The present invention relates to a pharmaceutical combination comprising (1) a first agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof and (2) a second agent which is a mTOR inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 25, 2013
    Date of Patent: August 9, 2016
    Assignee: Novartis AG
    Inventors: Shivang Doshi, Sunkyu Kim
  • Combination Therapy Comprising A CDK4/6 Inhibitor and a PI3K Inhibitor for Use in the Treatment of Cancer
    Publication number: 20160136171
    Abstract: A combination of a CDK4/6 inhibitor and a P3Kinase inhibitor for the treatment of cancer.
    Type: Application
    Filed: January 22, 2016
    Publication date: May 19, 2016
    Applicant: Novartis AG
    Inventors: Sunkyu Kim, Shivang Doshi, Kristy Haas, Steven Kovats, Alan Xizhong Huang, Yan Chen
  • Combination therapy comprising a CDK4/6 inhibitor and a P13K inhibitor for use in the treatment of cancer
    Patent number: 9271988
    Abstract: A combination of a CDK4/6 inhibitor and a P3Kinase inhibitor for the treatment of cancer.
    Type: Grant
    Filed: July 2, 2012
    Date of Patent: March 1, 2016
    Assignee: Novartis AG
    Inventors: Sunkyu Kim, Shivang Doshi, Kristy Haas, Steven Kovats, Alan Xizhong Huang, Yan Chen
  • Combination Comprising a Cyclin Dependent Kinase 4 or Cyclin Dependent Kinase (CDK4/6) Inhibitor for Treating Cancer
    Publication number: 20160008367
    Abstract: A combination of a CDK4/6 inhibitor and an mTOR inhibitor for the treatment of cancer.
    Type: Application
    Filed: July 16, 2015
    Publication date: January 14, 2016
    Applicant: Novartis AG
    Inventors: Maria Borland, Christopher Thomas Brain, Shivang Doshi, Sunkyu Kim, Jianguo Ma, Josh Murtie, Hong Zhang
  • PHARMACEUTICAL COMBINATION COMPRISING BINIMETINIB
    Publication number: 20150313902
    Abstract: A combination of a CDK4/6 inhibitor and a MEK inhibitor for the treatment of diseases such as cancer.
    Type: Application
    Filed: December 16, 2013
    Publication date: November 5, 2015
    Applicant: Novartis AG
    Inventors: Giordano CAPONIGRO, Scott DELACH, Shivang DOSHI, Thomas HORN-SPIROHN, Sunkyu KIM
  • COMBINATION THERAPY
    Publication number: 20150306104
    Abstract: The present invention relates to a pharmaceutical combination comprising (1) a first agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof and (2) a second agent which is a mTOR inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 25, 2013
    Publication date: October 29, 2015
    Applicant: Novartis AG
    Inventors: Shivang Doshi, Sunkyu Kim
  • Combination Therapy
    Publication number: 20140113909
    Abstract: A combination of a CDK4/6 inhibitor and an FGFR kinase inhibitor for the treatment of cancer.
    Type: Application
    Filed: June 28, 2012
    Publication date: April 24, 2014
    Applicant: Novartis AG
    Inventors: Sunkyu Kim, Shivang Doshi, Kristy Hans, Steven Kovats
  • Combination Therapy Comprising A CDK4/6 Inhibitor and a P13K Inhibitor for Use in the Treatment of Cancer
    Publication number: 20140107114
    Abstract: A combination of a CDK4/6 inhibitor and a P3Kinase inhibitor for the treatment of cancer.
    Type: Application
    Filed: July 2, 2012
    Publication date: April 17, 2014
    Applicant: Novartis AG
    Inventors: Sunkyu Kim, Shivang Doshi, Kristy Haas, Steven Kovats, Alan Xizhong Huang, Yan Chen
  • COMBINATION COMPRISING A CYCLIN DEPENDENT KINASE 4 OR CYCLIN DEPENDENT KINASE (CDK4/6) INHIBITOR FOR TREATING CANCER
    Publication number: 20130035336
    Abstract: A combination of a CDK4/8 inhibitor and an mTOR inhibitor for the treatment of cancer.
    Type: Application
    Filed: April 12, 2011
    Publication date: February 7, 2013
    Applicant: Novartis AG
    Inventors: Maria Borland, Christopher Thomas Brain, Shivang Doshi, Sunkyu Kim, Jianguo Ma, Josh Murtie, Hong Zhang